Liverpool Care Pathway for the Dying at Residential Care Homes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Margareta Brännström, Umeå University
ClinicalTrials.gov Identifier:
NCT01428206
First received: August 23, 2011
Last updated: June 13, 2013
Last verified: June 2013
  Purpose

Liverpool Care Pathway for the dying patient (LCP) was developed to transfer the care practice from the hospice setting to the hospital setting in UK. LCP is a pathway with standardized registration method to monitor the care and its results. The primary aim is to study the effects of LCP on dying patients symptom burden and communication with close relatives and health care professionals.


Condition Intervention
End-of-life Care
Other: Liverpool care pathway

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Liverpool Care Pathway for the Dying at Residential Care Homes

Resource links provided by NLM:


Further study details as provided by Umeå University:

Primary Outcome Measures:
  • quality of care [ Time Frame: one month to six months after the relatives death ] [ Designated as safety issue: Yes ]
    changes between the groups about values of symptom scores on the Edmonton assessment scale (ESAS) and the views of informal carers-evaluation of services (VOICES)assessed by close relative


Secondary Outcome Measures:
  • place of death [ Time Frame: the time of death ] [ Designated as safety issue: Yes ]
    changes between the groups

  • drug consumption [ Time Frame: the last three days before death ] [ Designated as safety issue: Yes ]

Enrollment: 260
Study Start Date: June 2009
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Liverpool care pathway
Liverpool care pathway for dying at nursing homes
Other: Liverpool care pathway
Liverpool care pathway is started tha last day in life for elderly at nursing homes
Other Names:
  • end-of-life care
  • palliative care
No Intervention: control
Usual care is performed for the control group

Detailed Description:

All residential care homes in Skellefteå municipality are included in the study and randomized either to control or intervention group. During the baseline period the care is provided as usual. During the intervention period the LCP is used for patients for whom the dying phase is diagnosed in the intervention group. Usual care is performed for the control group. After death of a patient a close relative fill in a questionnaire.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • nursing homes in Skellefteå municipality, Sweden

Exclusion Criteria:

-

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01428206

Locations
Sweden
Skellefteå municipality
Skellefteå, Västerbotten, Sweden
Sponsors and Collaborators
Umeå University
Investigators
Principal Investigator: Margareta Brännström, PhD Department of nursing, Umeå University
  More Information

No publications provided

Responsible Party: Margareta Brännström, RNT/PHD, Umeå University
ClinicalTrials.gov Identifier: NCT01428206     History of Changes
Other Study ID Numbers: LCP001
Study First Received: August 23, 2011
Last Updated: June 13, 2013
Health Authority: Sweden: Regional Ethical Review Board

Keywords provided by Umeå University:
palliative care
nursing homes
Liverpool care pathway

ClinicalTrials.gov processed this record on July 23, 2014